Related references
Note: Only part of the references are listed.Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1
Etienne Boulter et al.
NATURE CELL BIOLOGY (2010)
Loss of RhoB Expression Enhances the Myelodysplastic Phenotype of Mammalian Diaphanous-Related Formin mDia1 Knockout Mice
Aaron D. DeWard et al.
PLOS ONE (2009)
In vivo restoration of RhoB expression leads to ovarian tumor regression
B. Couderc et al.
CANCER GENE THERAPY (2008)
RhoA-GDP regulates RhoB protein stability -: Potential involvement of RhoGDIα
T. T. Giang Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer
P. Harter et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
RhoB affects macrophage adhesion, integrin expression and migration
Ann P. Wheeler et al.
EXPERIMENTAL CELL RESEARCH (2007)
Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile
Johannes Huelsenbeck et al.
BIOCHEMISTRY (2007)
Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter
F. L. Delarue et al.
ONCOGENE (2007)
Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma
D. I. Bellovin et al.
ONCOGENE (2006)
Histone modifications silence the GATA transcription factor genes in ovarian cancer
C. Caslini et al.
ONCOGENE (2006)
Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells
J Mazières et al.
EXPERIMENTAL CELL RESEARCH (2005)
Loss of RhoB expression in human lung cancer progression
J Mazieres et al.
CLINICAL CANCER RESEARCH (2004)
Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma
KJ Simpson et al.
CANCER RESEARCH (2004)
Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line
SW Wang et al.
ONCOGENE (2003)
Histone deacetylases
PA Marks et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Isoprenylation of RhoB is necessary for its degradation -: A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway
K Stamatakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The expression of Rho proteins decreases with human brain tumor progression: Potential tumor markers
MA Forget et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells
AX Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Ras and Rho regulation of the cell cycle and oncogenesis
K Pruitt et al.
CANCER LETTERS (2001)
Genes modulated by histone acetylation as new effecters of butyrate activity
F Della Ragione et al.
FEBS LETTERS (2001)
Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding
D Michaelson et al.
JOURNAL OF CELL BIOLOGY (2001)
RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors
AX Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice
Z Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRABP, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells
B Eickhoff et al.
BIOLOGICAL CHEMISTRY (2000)
Share Paper
